Actively Recruiting
Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy
Led by Beidahuang Industry Group General Hospital · Updated on 2025-11-24
200
Participants Needed
1
Research Sites
156 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a multicenter study. It plans to screen 200 patients with pulmonary nodule lesions with ground glass as the main body, take CT thin-layer scanning 3D reconstruction, apply AI and fragment omics technology to evaluate the risk of malignant transformation of pulmonary nodules, and use microwave ablation to treat pulmonary nodules and combine intraoperative rapid pathology technology to determine the nature of puncture tissue and the degree of ablation, and then explore the optimal ablation time and ablation power.
CONDITIONS
Official Title
Study on the Diagnosis of Ground-glass Lung Cancer by Microwave Ablation Combined With Puncture Biopsy
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 75 years or younger
- Ground-glass nodule patients with lesion size 3 cm or less in maximum axial diameter
- Refusal of radical surgery or inability to tolerate surgical treatment
- Normal coagulation function with platelet count at least 60 × 10⁹/L
- Eastern Cooperative Oncology Group (ECOG) performance status score of 2 or less
You will not qualify if you...
- Lesion size greater than 3 cm in maximum axial diameter
- Platelet count less than 50 × 10⁹/L
- Severe bleeding tendency or coagulation dysfunction not correctable shortly
- Severe chronic obstructive pulmonary disease, emphysema, pulmonary fibrosis, or pulmonary hypertension
- Anticoagulant or antiplatelet therapy stopped less than 5 days before ablation
- Severe heart, liver, kidney, or brain dysfunction
- Severe anemia, dehydration, or cachexia not correctable shortly
- Estimated survival less than 6 months
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Beidahuang Industry Group General Hospital
Harbin, Heilongjiang, China, 150088
Actively Recruiting
Research Team
M
Mingyang Liu
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NA
Model
SINGLE_GROUP
Primary Purpose
DIAGNOSTIC
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here